T4 Report evidence for the detection of non-endotoxin pyrogens by the whole blood monocyte activation test

Altex

Volumn 30, Issue 2, 2013, Pages 169-208

  Hasiwa, Nina ^a,b   Daneshian, Mardas ^a   Bruegger, Peter ^d   Fennrich, Stefan ^e   Hochadel, Astrid ^b   Hoffmann, Sebastian ^f   Rivera Mariani, Felix E ^c   Rockel, Christoph ^g   Schindler, Stefanie ^h   Spreitzer, Ingo ⁱ   Stoppelkamp, Sandra ^e   Vysyaraju, Kranthi ^c   Hartung, Thomas ^a,c  

^a UNIVERSITY OF KONSTANZ   (Germany)

^b AtaX Advice   (Germany)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d NOVARTIS PHARMA AG   (Switzerland)

^e UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^f Seh Consulting + Services   (Germany)

^g Enzler Hygiene AG   (Switzerland)

^h Foundation Animalfree Research   (Switzerland)

ⁱ PAUL EHRLICH INSTITUT   (Germany)

Author keywords

Fungal immune stimuli; Gram positive immune stimuli; Human whole blood; MAT; Non endotoxin pyrogens

Indexed keywords

DECTIN 1; DECTIN 2; DIALYSIS FLUID; ENDOGENOUS PYROGEN; ENDOTOXIN; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LECTIN RECEPTOR; LIPOTEICHOIC ACID; PYROGEN; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; DRUG;

ABDOMINAL PAIN; ACHOLEPLASMA LAIDLAWII; ALICYCLOBACILLUS ACIDOCALDARIUS; ANTIGEN RECOGNITION; ARTICLE; ASPERGILLUS FUMIGATUS; BACILLUS SUBTILIS; BACTERIAL CELL WALL; BIOFILM; CANDIDA ALBICANS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOKINE RESPONSE; DIARRHEA; ENDOTOXIN DETECTION; FEVER; FUNGAL STRUCTURES; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HORSESHOE CRAB; HUMAN; IMMUNE RESPONSE; IN VITRO STUDY; INNATE IMMUNITY; LIMIT OF DETECTION; LIMULUS LYSATE TEST; MEMBRANE COMPONENT; MOLECULAR RECOGNITION; MONOCYTE; NAUSEA; NONHUMAN; OLIGOMERIZATION; PATTERN RECOGNITION; PRACTICE GUIDELINE; PROTEIN CONTENT; SACCHAROMYCES CEREVISIAE; SENSITIVITY AND SPECIFICITY; SPECIES DIFFERENCE; THERMOREGULATION; TOXIN ANALYSIS; VALIDATION STUDY; VOMITING; ANIMAL; CHEMISTRY; DRUG CONTAMINATION; DRUG EFFECT; METHODOLOGY; REVIEW; STANDARD; TOXICITY TESTING;

ANIMALS; DRUG CONTAMINATION; HUMANS; MONOCYTES; PHARMACEUTICAL PREPARATIONS; PYROGENS; TOXICITY TESTS;

EID: 84876689035     PISSN: 1868596X     EISSN: 18688551     Source Type: Journal    
DOI: 10.14573/altex.2013.2.169     Document Type: Article

References (357)

1. Akira, S. And Hemmi, H. (2003). Recognition of pathogen-Associated molecular patterns by TLR family. Immunol Lett 85, 85-95.
2. al-Khalifa, I. J., Naidu, N. V., Nallari, V. R., et al. (1989). Effect of some penicillins on the sensitivity of limulus amoebocyte lysate test. J Pharm Pharmacol 41, 127-128.
3. Aliprantis, A. O., Yang, R. B., Mark, M. R., et al. (1999). Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science 285, 736-739.
4. Alluwaimi, A. M., Smith, H., and Sweet, C. (1994). Role of surface glycoproteins in influenza virus pyrogenicity. J Gen Virol 75, 2835-2840.
5. Anderson, J., Eller, M., Finkelman, M., et al. (2002). False positive endotoxin results in a DC product caused by (1-3)-beta-D-glucans acquired from a sterilizing cellulose filter. Cytotherapy 4, 557-559.
6. Andrade, S. S., Silveira, R. L., Schmidt, C. A., et al. (2003). Comparative evaluation of the human whole blood and human peripheral blood monocyte tests for pyrogens. Int J Pharm 265, 115-124.
7. Aulock, S. V., Deininger, S., Draing, C., et al. (2006). Gender difference in cytokine secretion on immune stimulation with LPS and LTA. J Interferon Cytokine Res 26, 887-892.
8. Auron, P. E. P., Webb, A. C., Rosenwasser, L. J., et al. (1984). Nucleotide sequence of human monocyte interleukin 1 precursor cDNA. Proc Natl Acad Sci USA 81, 7907-7911.
9. Bachmann, M., Horn, K., Poleganov, M. A., et al. (2006). Interleukin-18 secretion and Th1-like cytokine responses in human peripheral blood mononuclear cells under the influence of the toll-like receptor-5 ligand flagellin. Cell Microbiol 8, 289-300.
10. Baddiley, J. (1989). Bacterial cell walls and membranes. Discovery of the teichoic acids. Bioessays 10, 207-210.
11. Banerjee, S. And Mohanan, P. V. (2011). Inflammatory response to pyrogens determined by a novel ELISA method using human whole blood. J Immunol Methods 369, 146-153.
12. Bang, F. B. (1956). A bacterial disease of Limulus polyphemus. Bull Johns Hopkins Hosp 98, 325-351.
13. Barry, D. W., Mayner, R. E., Hochstein, H. D., et al. (1976). Comparative trial of influenza vaccines. II. Adverse reactions in children and adults. Am J Epidemiol 104, 47-59.
14. Barwick, V. S., Wooten, M. H., Bradfield, J. F., et al. (1994). Fever of unknown origin: due to C. Albicans or other fungi acting on the hypothalamus? Brain Res 635, 1-8.
15. Bate, C. A., Taverne, J., and Playfair, J. H. (1989). Soluble malarial antigens are toxic and induce the production of tumour necrosis factor in vivo. Immunology 66, 600-605.
16. Becker, S., Quay, J., and Soukup, J. (1991). Cytokine (tumor necrosis factor, IL-6, and IL-8) production by respiratory syncytial virus-infected human alveolar macrophages. J Immunol 147, 4307-4312.
17. Bellentani, L. (1982). Cyclic and chronobiological considerations when employing the rabbit fever test. Prog Clin Biol Res 93, 329-342.
18. Beloeil, J. C., Esnault, C., Fetizon, M., et al. (1980). Synthesis and pyrogenic effect of 3 alpha, 7 alpha-dihydroxy-5 beta-Androstan-17-one and 3 alpha-hydroxy-5 beta-Androstane-7, 17-dione. Steroids 35, 281-293.
19. Bencsics, A., Elenkov, I. J., and Vizi, E. S. (1995). Alpha 2-, alpha 2A-, alpha 2B/2C-Adrenoceptor subtype antagonists prevent lipopolysaccharide- induced fever response in rabbits. Brain Res 705, 302-306.
20. Benevent, D., El Akoum, N., Lagarde, C., et al. (1984). [Danger of the intraperitoneal administration of amphotericin B during continuous ambulatory peritoneal dialysis]. Presse Med 13, 1844.
21. Benz, R. (1988). Structure and function of porins from gram-negative bacteria. Annu Rev Microbiol 42, 359-393.
22. Bertholet, S., Horne, D. J., Laughlin, E. M., et al. (2011). Effect of chemotherapy on whole-blood cytokine responses to Mycobacterium tuberculosis antigens in a small cohort of patients with pulmonary tuberculosis. Clin Vaccine Immunol 18, 1378-1386.
23. Beutler, B., Hoebe, K., Du, X., et al. (2003). How we detect microbes and respond to them: the Toll-like receptors and their transducers. J Leukoc Biol 74, 479-485.
24. Bhakdi, S., Grimminger, F., Suttorp, N., et al. (1994). Proteinaceous bacterial toxins and pathogenesis of sepsis syndrome and septic shock: the unknown connection. Med Microbiol Immunol 183, 119-144.
25. Bodel, P. And Dillard, M. (1968). Studies on steroid fever: I. Production of leukocyte pyrogen in vitro by etiocholanolone. J Clin Invest 47, 107-117.
26. Bodet, C. And Grenier, D. (2010). Synergistic effects of lipopolysaccharides from periodontopathic bacteria on pro-inflammatory cytokine production in an ex vivo whole blood model. Mol Oral Microbiol 25, 102-111.
27. Bohrer, D., Horner, R., do Nascimento, P. C., et al. (2001). Interference in the Limulus amebocyte lysate assay for endotoxin determination in peritoneal dialysis fluids and concentrates for hemodialysis. J Pharm Biomed Anal 26, 811-818.
28. Bone, R. C. (1993). How gram-positive organisms cause sepsis. J Crit Care 8, 51-59.
29. Bone, R. C. (1994). Gram-positive organisms and sepsis. Arch Intern Med 154, 26-34.
30. Boneca, I. G. (2005). The role of peptidoglycan in pathogenesis. Curr Opin Microbiol 8, 46-53.
31. Booth, C. (1986). The limulus amoebocyte lysate (LAL) assay - a replacement for the rabbit pyrogen test. Dev Biol Stand 64, 271-275.
32. Brandenburg, K., Howe, J., Gutsman, T., et al. (2009). The expression of endotoxic activity in the Limulus test as compared to cytokine production in immune cells. Curr Med Chem 16, 2653-2660.
33. Braude, A. I., Mc, C. J., and Douglas, H. (1960). Fever from pathogenic fungi. J Clin Invest 39, 1266-1276.
34. Brent, J. (2001). Current management of ethylene glycol poisoning. Drugs 61, 979-988.
35. Brown, G. D. And Gordon, S. (2001). Immune recognition. A new receptor for beta-glucans. Nature 413, 36-37.
36. Brown, G. D., Herre, J., Williams, D. L., et al. (2003). Dectin-1 mediates the biological effects of beta-glucans. J Exp Med 197, 1119-1124.
37. Bubeck Wardenburg, J., Williams, W. A., and Missiakas, D. (2006). Host defenses against Staphylococcus aureus infection require recognition of bacterial lipoproteins. Proc Natl Acad Sci U S A 103, 13831-13836.
38. Bucki, R., Byfield, F. J., Kulakowska, A., et al. (2008). Extracellular gelsolin binds lipoteichoic acid and modulates cellular response to proinflammatory bacterial wall components. J Immunol 181, 4936-4944.
39. Bunk, S., Sigel, S., Metzdorf, D., et al. (2010). Internalization and coreceptor expression are critical for TLR2-mediated recognition of lipoteichoic acid in human peripheral blood. J Immunol 185, 3708-3717.
40. Carlin, G. And Viitanen, E. (2005). In vitro pyrogenicity of the diphtheria, tetanus and acellular pertussis components of a trivalent vaccine. Vaccine 23, 3709-3715.
41. Carson, L. A., Bland, L. A., Cusick, L. B., et al. (1988). Prevalence of nontuberculous mycobacteria in water supplies of hemodialysis centers. Appl Environ Microbiol 54, 3122-3125.
42. Castro, M., Bjoraker, J. A., Rohrbach, M. S., et al. (1996). Candida albicans induces the release of inflammatory mediators from human peripheral blood monocytes. Inflammation 20, 107-122.
43. Chamaillard, M., Hashimoto, M., Horie, Y., et al. (2003). An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat Immunol 4, 702-707.
44. Chang, D. M. And Shaio, M. F. (1994). Production of interleukin-1 (IL-1) and IL-1 inhibitor by human monocytes exposed to dengue virus. J Infect Dis 170, 811-817.
45. Cherid, H., Foto, M., and Miller, J. D. (2011). Performance of two different Limulus amebocyte lysate assays for the quantitation of fungal glucan. J Occup Environ Hyg 8, 540-543.
46. Cohen, Y., Bahri, F., Bruneau, J., et al. (1986). [Detection of endotoxins in radiopharmaceutical preparations - III. Limulus test assessment using radiopharmaceutical preparations; correlation with the rabbit pyrogen test]. Int J Nucl Med Biol 12, 477-481.
47. Coleman, M. D. (1995). Dapsone toxicity: some current perspectives. Gen Pharmacol 26, 1461-1467.
48. Cooper, J. F., Hochstein, H. D., and Seligmann, E. B., Jr. (1972). The Limulus test for endotoxin (Pyrogen) in radiopharmaceuticals and biologicals. Bull Parenter Drug Assoc 26, 153-162.
49. Cooper, J. F. (1979). Acceptance of the Limulus test as an alternative pyrogen test for radiopharmaceutical and intrathecal drugs. Prog Clin Biol Res 29, 345-352.
50. Cooper, J. F., Weary, M. E., and Jordan, F. T. (1997). The impact of non-endotoxin LAL-reactive materials on Limulus amebocyte lysate analyses. PDA J Pharm Sci Technol 51, 2-6.
51. Costachel, C., Coddeville, B., Latge, J. P., et al. (2005). Glycosylphosphatidylinositol-Anchored fungal polysaccharide in Aspergillus fumigatus. J Biol Chem 280, 39835-39842.
52. Cowdery, J. S., Chace, J. H., Yi, A. K., et al. (1996). Bacterial DNA induces NK cells to produce IFN-gamma in vivo and increases the toxicity of lipopolysaccharides. J Immunol 156, 4570-4575.
53. Cradock, J. C., Vishnuvajjala, B. R., Chin, T. F., et al. (1986). Uridine-induced hyperthermia in the rabbit. J Pharm Pharmacol 38, 226-229.
54. Cranston, W. I. And Luff, R. H. (1972). The role of noradrenaline in the rabbit brain during pyrogen-induced fever. J Physiol 225, 66P-67P.
55. Cusumano, V., Tufano, M. A., Mancuso, G., et al. (1997). Porins of Pseudomonas aeruginosa induce release of tumor necrosis factor alpha and interleukin-6 by human leukocytes. Infect Immun 65, 1683-1687.
56. Dabbah, R., Ferry, E., Jr., Gunther, D. A., et al. (1980). Pyrogenicity of E. coli 055:b5 endotoxin by the USP rabbit test - a HIMA collaborative study. J Parenter Drug Assoc 34, 212-216.
57. Dale, H. H. (1929). Croonian lectures on some chemical factors in the control of the circulation. The Lancet 213, 1285-1290.
58. Daneshian, M. (2006). Detection and characterization of the immunostimulatory properties of airborne pyrogens. Universität Konstanz. http://nbn-resolving.de/urn:nbn:de:bsz:352-opus-23677
59. Daneshian, M., Guenther, A., Wendel, A., et al. (2006). In vitro pyrogen test for toxic or immunomodulatory drugs. J Immunol Methods 313, 169-175.
60. Daneshian, M., Wendel, A., Hartung, T., et al. (2008). High sensitivity pyrogen testing in water and dialysis solutions. J Immunol Methods 336, 64-70.
61. Daneshian, M., von Aulock, S., and Hartung, T. (2009). Assessment of pyrogenic contaminations with validated human whole-blood assay. Nat Protoc 4, 1709-1721.
62. Dehus, O., Hartung, T., and Hermann, C. (2006). Endotoxin evaluation of eleven lipopolysaccharides by whole blood assay does not always correlate with Limulus amebocyte lysate assay. J Endotoxin Res 12, 171-180.
63. Deininger, S., Stadelmaier, A., von Aulock, S., et al. (2003). Definition of structural prerequisites for lipoteichoic acid-inducible cytokine induction by synthetic derivatives. J Immunol 170, 4134-4138.
64. Deininger, S., Figueroa-Perez, I., Sigel, S., et al. (2007). Use of synthetic derivatives to determine the minimal active structure of cytokine-inducing lipoteichoic acid. Clin Vaccine Immunol 14, 1629-1633.
65. Deininger, S., Traub, S., Aichele, D., et al. (2008). Presentation of lipoteichoic acid potentiates its inflammatory activity. Immunobiology 213, 519-529.
66. Dennehy, K. M. And Brown, G. D. (2007). The role of the beta-glucan receptor Dectin-1 in control of fungal infection. J Leukoc Biol 82, 253-258.
67. Derijk, R. H., Strijbos, P. J., van Rooijen, N., et al. (1993). Fever and thermogenesis in response to bacterial endotoxin involve macrophage-dependent mechanisms in rats. Am J Physiol 265, R1179-1183.
68. Dinarello, C. A., Elin, R. J., Chedid, L., et al. (1978). The pyrogenicity of the synthetic adjuvant muramyl dipeptide and two structural analogues. J Infect Dis 138, 760-767.
69. Dinarello, C. A., O'Connor, J. V., LoPreste, G., et al. (1984). Human leukocytic pyrogen test for detection of pyrogenic material in growth hormone produced by recombinant Escherichia coli. J Clin Microbiol 20, 323-329.
70. Dinarello, C. A. (1996). Thermoregulation and the pathogenesis of fever. Infect Dis Clin North Am 10, 433-449.
71. Dinarello, C. A. (2000). Proinflammatory cytokines. Chest 118, 503-508.
72. Dinarello, C. A. (2004). Infection, fever, and exogenous and endogenous pyrogens: some concepts have changed. J Endotoxin Res 10, 201-222.
73. Ding, J. L. And Ho, B. (2001). A new era in pyrogen testing. Trends Biotechnol 19, 277-281.
74. DiRita, V. J., Murthy, P. K., Dennis, V. A., et al. (2000). Interleukin-10 modulates proinflammatory cytokines in the human monocytic cell line THP-1 stimulated with Borrelia burgdorferi lipoproteins. Infect Immun 68, 6663-6669.
75. Draing, C., Pfitzenmaier, M., Zummo, S., et al. (2006). Comparison of lipoteichoic acid from different serotypes of Streptococcus pneumoniae. J Biol Chem 281, 33849-33859.
76. Draing, C., Traub, S., Deininger, S., et al. (2008). Polypropylene glycol is a selective binding inhibitor for LTA and other structurally related TLR2 agonists. Eur J Immunol 38, 797-808.
77. Driessen, C., Hirv, K., Kirchner, H., et al. (1995). Zinc regulates cytokine induction by superantigens and lipopolysaccharide. Immunology 84, 272-277.
78. Drummond, R. A., Saijo, S., Iwakura, Y., et al. (2011). The role of Syk/CARD9 coupled C-type lectins in antifungal immunity. Eur J Immunol 41, 276-281.
79. Duff, G. W. And Atkins, E. (1982). The detection of endotoxin by in vitro production of endogenous pyrogen: comparison with limulus amebocyte lysate gelation. J Immunol Methods 52, 323-331.
80. Duner, K. I. (1995). The importance of the quality of water in Limulus Amebocyte Lysate tests. PDA J Pharm Sci Technol 49, 119-121.
81. Dziarski, R. (2004). Peptidoglycan recognition proteins (PGRPs). Mol Immunol 40, 877-886.
82. Dziarski, R. And Gupta, D. (2005). Peptidoglycan recognition in innate immunity. J Endotoxin Res 11, 304-310.
83. ECVAM (2006). ESAC Statement on the validity of in-vitro pyrogen tests. http://ecvam.jrc.it/ft-doc/ESAC statement pyrogenicity 20060516.pdf
84. Elin, R. J. And Wolff, S. M. (1973). Nonspecificity of the limulus amebocyte lysate test: positive reactions with polynucleotides and proteins. J Infect Dis 128, 349-352.
85. Elin, R. J. And Utter, A. E. (1980). Positive Limulus amoebocyte lysate reactions with polyriboinosinic acid x polyribocytidylic acid. J Clin Microbiol 12, 502-505.
86. Ellis, M., Al-Ramadi, B., Finkelman, M., et al. (2008). Assessment of the clinical utility of serial beta-D-glucan concentrations in patients with persistent neutropenic fever. J Med Microbiol 57, 287-295.
87. EDQM (2010). European Pharmacopoeia. Ph. Eur. 7th Edition, Chapter 2.6.30. http://www.edqm.eu/en/edqm-homepage-628.html
88. EMEA (2009). Guideline on the replacement of rabbit pyrogen testing by an alternative test for plasma derived products. http:// www.emea.europa.eu/docs/ en-GB/document-library/Scientific-guideline/2009/09/WC500003599.pdf
89. EU - European Union (2010). Directive 2010/63/EU of the European Parliament and of the Council of 22 September 2010 on the protection of animals used for scientific purposes. http://eur-lex.europa.eu/LexUriServ/LexUriServ.do? uri=OJ:L:2010:276:0033:0079:en:PDF
90. Engstad, C. S., Engstad, R. E., Olsen, J. O., et al. (2002). The effect of soluble beta-1,3-glucan and lipopolysaccharide on cytokine production and coagulation activation in whole blood. Int Immunopharmacol 2, 1585-1597.
91. Eperon, S., De Groote, D., Werner-Felmayer, G., et al. (1997). Human monocytoid cell lines as indicators of endotoxin: comparison with rabbit pyrogen and Limulus amoebocyte lysate assay. J Immunol Methods 207, 135-145.
92. Eriksson, M., Meadows, S. K., Basu, S., et al. (2006). TLRs mediate IFN-gamma production by human uterine NK cells in endometrium. J Immunol 176, 6219-6224.
93. Fan, X., Stelter, F., Menzel, R., et al. (1999). Structures in Bacillus subtilis are recognized by CD14 in a lipopolysaccharide binding protein-dependent reaction. Infect Immun 67, 2964-2968.
94. FDA (2009). Letter from Norris E. Alderson, PhD, FDA Associate Commissioner for Science, to RADM William S. Stokes, Director NICEATM. http://iccvam.niehs.nih.gov/methods/pyrogen/transmitNov08/FDA-Response.pdf
95. Fennrich, S., Fischer, M., Hartung, T., et al. (1998). [Evaluation and further development of a pyrogenicity assay based on human whole blood]. ALTEX 15, 123-128.
96. Fennrich, S., Fischer, M., Hartung, T., et al. (1999a). Detection of endotoxins and other pyrogens using human whole blood. Dev Biol Stand 101, 131-139.
97. Fennrich, S., Wendel, A., and Hartung, T. (1999b). New applications of the human whole blood pyrogen assay (PyroCheck). ALTEX 16, 146-149.
98. Figueroa-Perez, I., Stadelmaier, A., Morath, S., et al. (2005). Synthesis of structural variants of Staphylococcus aureus lipoteichoic acid (LTA). Tetrahedron: Asymmetry 16, 493-506.
99. Figueroa-Perez, I., Stadelmaier, A., Deininger, S., et al. (2006). Synthesis of Staphylococcus aureus lipoteichoic acid derivatives for determining the minimal structural requirements for cytokine induction. Carbohydr Res 341, 2901-2911.
100. Fischer, M., Keller-Stanislawski, B., Schober-Bendixen, S., et al. (2001). [Effect of the preservative thiomersal on the release of interleukin-1 beta from human peripheral blood cells]. ALTEX 18, 47-49.
101. Fitzgerald, D. And Pastan, I. (1993). Pseudomonas exotoxin and recombinant immunotoxins derived from it. Ann N Y Acad Sci 685, 740-745.
102. Flanigan, M. J., Accone, Q., and Laburn, H. P. (1992). Amitriptyline attenuates the febrile response to a pyrogen in rabbits. J Basic Clin Physiol Pharmacol 3, 19-32.
103. Forland, D. T., Johnson, E., Saetre, L., et al. (2011). Effect of an extract based on the medicinal mushroom Agaricus blazei Murill on expression of cytokines and calprotectin in patients with ulcerative colitis and Crohn's disease. Scand J Immunol 73, 66-75.
104. Francois, C., Neveu, J., Sauvaire, D., et al. (2006). In vitro pyrogenicity of Gram-positive bacteria - validation of the kit using fresh human whole blood. Pharmeur Sci Notes 2006, 17-21.
105. Fredheim, E. G., Granslo, H. N., Flaegstad, T., et al. (2011). Staphylococcus epidermidis polysaccharide intercellular adhesin activates complement. FEMS Immunol Med Microbiol 63, 269-280.
106. Frieling, J. T., Mulder, J. A., Hendriks, T., et al. (1997). Differential induction of pro- and anti-inflammatory cytokines in whole blood by bacteria: effects of antibiotic treatment. Antimicrob Agents Chemother 41, 1439-1443.
107. Fumarola, D., Munno, I., Marcuccio, C., et al. (1986). Endotoxin-like activity associated with Lyme disease Borrelia. Zentralbl Bakteriol Mikrobiol Hyg A 263, 142-145.
108. Gagalo, I. T., Hac, E. E., Matuszek, M. T., et al. (1995). Thermoregulatory activity of sodium nitroprusside and arginine vasopressin. Gen Pharmacol 26, 393-397.
109. Gagalo, I. T., Hac, E. E., Korolkiewicz, K. Z., et al. (1996). Do sodium nitroprusside and L-NAMEaffect pyrogen fever in rabbits? Acta Physiol Hung 84, 289-290.
110. Gagalo, I. T. And Matuszek, M. T. (1997). The effect of N6-cyclohexyladenosine and 5'-(N-cyclopropyl)- carboxamidoadenosine on pyrogen fever in rabbits. Ann N Y Acad Sci 813, 353-359.
111. Gaines Das, R. E., Brugger, P., Patel, M., et al. (2004). Monocyte activation test for pro-inflammatory and pyrogenic contaminants of parenteral drugs: test design and data analysis. J Immunol Methods 288, 165-177.
112. Galdiero, F., Tufano, M. A., Galdiero, M., et al. (1990). Inflammatory effects of Salmonella typhimurium porins. Infect Immun 58, 3183-3186.
113. Galdiero, F., Sommese, L., Scarfogliero, P., et al. (1994). Biological activities - lethality, Shwartzman reaction and pyrogenicity - of Salmonella typhimurium porins. Microb Pathog 16, 111-119.
114. Gantner, B. N., Simmons, R. M., Canavera, S. J., et al. (2003). Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2. J Exp Med 197, 1107-1117.
115. Gee, A. P., Sumstad, D., Stanson, J., et al. (2008). A multicenter comparison study between the Endosafe PTS rapid-release testing system and traditional methods for detecting endotoxin in cell-therapy products. Cytotherapy 10, 427-435.
116. Geluk, A., van der Ploeg-van Schip, J. J., van Meijgaarden, K. E., et al. (2010). Enhancing sensitivity of detection of immune responses to Mycobacterium leprae peptides in whole-blood assays. Clin Vaccine Immunol 17, 993-1004.
117. Gewirtz, A. T., Navas, T. A., Lyons, S., et al. (2001). Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. J Immunol 167, 1882-1885.
118. Giambartolomei, G. H., Dennis, V. A., Lasater, B. L., et al. (2002). Autocrine and exocrine regulation of interleukin-10 production in THP-1 cells stimulated with Borrelia burgdorferi lipoproteins. Infect Immun 70, 1881-1888.
119. Girardin, S. E., Boneca, I. G., Carneiro, L. A., et al. (2003a). Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science 300, 1584-1587.
120. Girardin, S. E., Travassos, L. H., Herve, M., et al. (2003b). Peptidoglycan molecular requirements allowing detection by Nod1 and Nod2. J Biol Chem 278, 41702-41708.
121. Gokal, R., Ramos, J. M., Ward, M. K., et al. (1981). " Eosinophilic" peritonitis in continuous ambulatory peritoneal dialysis (CAPD). Clin Nephrol 15, 328-330.
122. Gong, J. H., Sprenger, H., Hinder, F., et al. (1991). Influenza A virus infection of macrophages. Enhanced tumor necrosis factor-Alpha (TNF-Alpha) gene expression and lipopolysaccharide-triggered TNF-Alpha release. J Immunol 147, 3507-3513.
123. Goris, M. G., Wagenaar, J. F., Hartskeerl, R. A., et al. (2011). Potent innate immune response to pathogenic leptospira in human whole blood. PLoS One 6, e18279.
124. Grangette, C., Nutten, S., Palumbo, E., et al. (2005). Enhanced antiinflammatory capacity of a Lactobacillus plantarum mutant synthesizing modified teichoic acids. Proc Natl Acad Sci U S A 102, 10321-10326.
125. Greisman, S. E. And Hornick, R. B. (1969). Comparative pyrogenic reactivity of rabbit and man to bacterial endotoxin. Proc Soc Exp Biol Med 131, 1154-1158.
126. Gross, O., Gewies, A., Finger, K., et al. (2006). Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity. Nature 442, 651-656.
127. Gutsmann, T., Howe, J., Zahringer, U., et al. (2010). Structural prerequisites for endotoxic activity in the Limulus test as compared to cytokine production in mononuclear cells. Innate Immun 16, 39-47.
128. Hackett, S. P. And Stevens, D. L. (1992). Streptococcal toxic shock syndrome: synthesis of tumor necrosis factor and interleukin-1 by monocytes stimulated with pyrogenic exotoxin A and streptolysin O. J Infect Dis 165, 879-885.
129. Hadley, J. S., Wang, J. E., Foster, S. J., et al. (2005). Peptidoglycan of Staphylococcus aureus upregulates monocyte expression of CD14, Toll-like receptor 2 (TLR2), and TLR4 in human blood: possible implications for priming of lipopolysaccharide signaling. Infect Immun 73, 7613-7619.
130. Hall-Stoodley, L., Costerton, J. W., and Stoodley, P. (2004). Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol 2, 95-108.
131. Hanage, W. P. And Cohen, J. (2002). Stimulation of cytokine release and adhesion molecule expression by products of Viridans streptococci. J Infect Dis 185, 357-367.
132. Hansen, E. W. And Christensen, J. D. (1990). Comparison of cultured human mononuclear cells, Limulus amebocyte lysate and rabbits in the detection of pyrogens. J Clin Pharm Ther 15, 425-433.
133. Harmon, P., Cabral-Lilly, D., Reed, R. A., et al. (1997). The release and detection of endotoxin from liposomes. Anal Biochem 250, 139-146.
134. Hartung, T. And Wendel, A. (1995). [Detection of Pyrogens using human whole blood]. ALTEX 12, 70-75.
135. Hartung, T., Sauer, A., and Wendel, A. (1996). Testing of immunomodulatory properties in vitro. Dev Biol Stand 86, 85-96.
136. Hartung, T. And Wendel, A. (1996). Detection of pyrogens using human whole blood. In vitro Toxicol 9, 353-359.
137. Hartung, T., Sauer, A., Hermann, C., et al. (1997). Overactivation of the immune system by translocated bacteria and bacterial products. Scand J Gastroenterol, Suppl 222, 98-99.
138. Hartung, T., Crameri, R., and Wendel, A. (1998). [Development of a pyrogen test based on rabbit blood]. ALTEX 15, 17-18.
139. Hartung, T., Aaberge, I., Berthold, S., et al. (2001). Novel pyrogen tests based on the human fever reaction. The report and recommendations of ECVAM Workshop 43. European Centre for the Validation of Alternative Methods. European Centre for the Validation of Alternative Methods. Altern Lab Anim 29, 99-123.
140. Hartung, T. (2002). Comparison and validation of novel pyrogen tests based on the human fever reaction. Altern Lab Anim 30, Suppl 2, 49-51.
141. Hashimoto, M., Tawaratsumida, K., Kariya, H., et al. (2006). Not lipoteichoic acid but lipoproteins appear to be the dominant immunobiologically active compounds in Staphylococcus aureus. J Immunol 177, 3162-3169.
142. Hasiwa, M., Kullmann, K., von Aulock, S., et al. (2007). An in vitro pyrogen safety test for immune-stimulating components on surfaces. Biomaterials 28, 1367-1375.
143. Hayashi, F., Smith, K. D., Ozinsky, A., et al. (2001). The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410, 1099-1103.
144. Heil, F., Hemmi, H., Hochrein, H., et al. (2004). Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303, 1526-1529.
145. Henderson, B., Poole, S., and Wilson, M. (1996). Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis. Microbiol Rev 60, 316-341.
146. Henderson, B. And Wilson, M. (1996). Cytokine induction by bacteria: beyond lipopolysaccharide. Cytokine 8, 269-282.
147. Henneke, P., Morath, S., Uematsu, S., et al. (2005). Role of lipoteichoic acid in the phagocyte response to group B streptococcus. J Immunol 174, 6449-6455.
148. Hermann, C., Spreitzer, I., Schroder, N. W., et al. (2002). Cytokine induction by purified lipoteichoic acids from various bacterial species - role of LBP, sCD14, CD14 and failure to induce IL-12 and subsequent IFN-gamma release. Eur J Immunol 32, 541-551.
149. Hermann, C., von Aulock, S., Graf, K., et al. (2003). A model of human whole blood lymphokine release for in vitro and ex vivo use. J Immunol Methods 275, 69-79.
150. Herwaldt, L. A., Gorman, G. W., McGrath, T., et al. (1984). A new Legionella species, Legionella feeleii species nova, causes Pontiac fever in an automobile plant. Ann Intern Med 100, 333-338.
151. Hill, A. B. (1965). The Environment and Disease: Association or Causation? Proc R Soc Med 58, 295-300.
152. Hitchcock, P. J. And Morrison, D. C. (1984). The protein components of bacterial endotoxins. In E. T. Rietschel (eds.), Chemistry of Endotoxin. Elsevier.
153. Hoebe, K., Georgel, P., Rutschmann, S., et al. (2005). CD36 is a sensor of diacylglycerides. Nature 433, 523-527.
154. Hoffman, R. S. (2000). Does consensus equal correctness? J Toxicol Clin Toxicol 38, 689-690.
155. Hoffmann, S., Peterbauer, A., Schindler, S., et al. (2005). International validation of novel pyrogen tests based on human monocytoid cells. J Immunol Methods 298, 161-173.
156. Holm, S. E. (1982). Gram-positive microorganisms in sepsis. Scand J Infect Dis Suppl 31, 68-77.
157. Holtkamp, B., Schmitz, G., and Hartung, T. (2010). In vitro-Pyrogentest - Nachweis eines breiten Pyrogenspektrums im Monozyten-Aktivierungstest. Biospektrum 16, 779-781.
158. Hort, E. C. And Penfold, W. J. (1912). Microorganisms and their relation to fever: Preliminary Communication. J Hyg (Lond) 12, 361-390.
159. Houldsworth, S., Andrew, P. W., and Mitchell, T. J. (1994). Pneumolysin stimulates production of tumor necrosis factor alpha and interleukin-1 beta by human mononuclear phagocytes. Infect Immun 62, 1501-1503.
160. Howell, W. H. (1885). Observations upon the chemical composition and coagulation of the blood of Limulus polyphemus, Callinectes hastatus, and Cucumaria sp. Johns Hopkins University Circular 43, 4-5.
161. Hsu, Y. M., Zhang, Y., You, Y., et al. (2007). The adaptor protein CARD9 is required for innate immune responses to intracellular pathogens. Nat Immunol 8, 198-205.
162. Huang, L. Y., Dumontelle, J. L., Zolodz, M., et al. (2009). Use of toll-like receptor assays to detect and identify microbial contaminants in biological products. J Clin Microbiol 47, 3427-3434.
163. Huang, W. T., Lin, M. T., and Won, S. J. (1997a). Staphylococcal enterotoxin A-induced fever is associated with increased circulating levels of cytokines in rabbits. Infect Immun 65, 2656-2662.
164. Huang, W. T., Lin, M. T., and Won, S. J. (1997b). Mechanisms and sites of pyrogenic action exerted by staphylococcal enterotoxin A in rabbits. Neurosci Lett 236, 53-56.
165. Hull, D., McIntyre, J., and Vinter, J. (1993). Age-related changes in endotoxin sensitivity and the febrile response of newborn rabbits. Biol Neonate 63, 370-379.
166. Hurley, J. C., Tosolini, F. A., and Louis, W. J. (1991). Quantitative Limulus lysate assay for endotoxin and the effect of plasma. J Clin Pathol 44, 849-854.
167. Huszar, G., Jenei, B., Szabo, G., et al. (2002). Detection of pyrogens in intravenous IgG preparations. Biologicals 30, 77-83.
168. ICCVAM (2008). ICCVAM Test Method Evaluation Report: Validation Status of Five In Vitro Test Methods Proposed for Assessing Potential Pyrogenicity of Pharmaceuticals and Other Products. http://iccvam.niehs.nih.gov/methods/pyrogen/ pyr-tmer.htm
169. ICCVAM (2009). Test Method Evaluation Report and Final Background Review Documents. http://iccvam.niehs.nih. gov/methods/pyrogen/pyrogen.htm
170. Ikeda, Y., Adachi, Y., Ishibashi, K., et al. (2005). Activation of toll-like receptor-mediated NF-kappa beta by zymosan-derived water-soluble fraction: possible contribution of endotoxin-like substances. Immunopharmacol Immunotoxicol 27, 285-298.
171. Ikemura, K., Ikegami, K., Shimazu, T., et al. (1989). False-positive result in Limulus test caused by Limulus amebocyte lysate-reactive material in immunoglobulin products. J Clin Microbiol 27, 1965-1968.
172. Into, T., Kanno, Y., Dohkan, J., et al. (2007). Pathogen recognition by Toll-like receptor 2 activates Weibel-Palade body exocytosis in human aortic endothelial cells. J Biol Chem 282, 8134-8141.
173. Ishiguro, T., Yasui, M., Nakade, Y., et al. (2007). Extrinsic allergic alveolitis with eosinophil infiltration induced by 1,1,1,2-tetrafluoroethane (HFC-134a): a case report. Intern Med 46, 1455-1457.
174. Jacinto, R., Hartung, T., McCall, C., et al. (2002). Lipopolysaccharide- and lipoteichoic acid-induced tolerance and cross-tolerance: distinct alterations in IL-1 receptor-Associated kinase. J Immunol 168, 6136-6141.
175. Jagger, M. P., Huo, Z., and Riches, P. G. (2002). Inflammatory cytokine (interleukin 6 and tumour necrosis factor alpha) release in a human whole blood system in response to Streptococcus pneumoniae serotype 14 and its capsular polysaccharide. Clin Exp Immunol 130, 467-474.
176. Jakeman, K. J., Bird, C. R., Thorpe, R., et al. (1991). Nature of the endogenous pyrogen (EP) induced by influenza viruses: lack of correlation between EP levels and content of the known pyrogenic cytokines, interleukin 1, interleukin 6 and tumour necrosis factor. J Gen Virol 72 (Pt 3), 705-709.
177. Jemmett, K., Macagno, A., Molteni, M., et al. (2008). A cyanobacterial lipopolysaccharide antagonist inhibits cytokine production induced by Neisseria meningitidis in a human whole-blood model of septicemia. Infect Immun 76, 3156-3163.
178. Jimenez, L., Rana, N., Travers, K., et al. (2010). Evaluation of the Endosafe(R) Portable Testing System™ for the Rapid Analysis of Biopharmaceutical Samples. PDA J Pharm Sci Technol 64, 211-221.
179. Jin, M. S., Kim, S. E., Heo, J. Y., et al. (2007). Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-Acylated lipopeptide. Cell 130, 1071-1082.
180. Johannsen, L., Wecke, J., Obal, F., Jr., et al. (1991). Macrophages produce somnogenic and pyrogenic muramyl peptides during digestion of staphylococci. Am J Physiol 260, R126-133.
181. Johnson, E., Forland, D. T., Saetre, L., et al. (2009). Effect of an extract based on the medicinal mushroom Agaricus blazei murill on release of cytokines, chemokines and leukocyte growth factors in human blood ex vivo and in vivo. Scand J Immunol 69, 242-250.
182. Johnson, R. A. (2000). The immune compromised host in the twenty-first century: management of mucocutaneous infections. Semin Cutan Med Surg 19, 19-61.
183. Jouneau, S., Bonizec, M., Belleguic, C., et al. (2011). Anti-inflammatory effect of fluvastatin on IL-8 production induced by Pseudomonas aeruginosa and Aspergillus fumigatus antigens in cystic fibrosis. PLoS One 6, e22655.
184. Jurk, M., Heil, F., Vollmer, J., et al. (2002). Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848. Nat Immunol 3, 499.
185. Kamble, R. R., Shinde, V. S., Madhale, S. P., et al. (2010). Study of cytokine response against panel of purified Mycobacterium leprae antigens by using whole blood assay in subjects residing in a resettlement village of cured leprosy patients. Indian J Lepr 82, 23-31.
186. Karanicolas, S., Oreopoulos, D. G., Izatt, S., et al. (1977). Epidemic of aseptic peritonitis caused by endotoxin during chronic peritoneal dialysis. N Engl J Med 296, 1336-1337.
187. Karatan, E. And Watnick, P. (2009). Signals, regulatory networks, and materials that build and break bacterial biofilms. Microbiol Mol Biol Rev 73, 310-347.
188. Keene, W. R., Silberman, H. R., and Landy, M. (1961). Observations on the pyrogenic response and its application to the bioassay of endotoxin. J Clin Invest 40, 295-301.
189. Kikkert, R., Bulder, I., de Groot, E. R., et al. (2007). Potentiation of Toll-like receptor-induced cytokine production by (1-3)-beta-D-glucans: implications for the monocyte activation test. J Endotoxin Res 13, 140-149.
190. Kim, H. G., Gim, M. G., Kim, J. Y., et al. (2007a). Lipoteichoic acid from Lactobacillus plantarum elicits both the production of interleukin-23p19 and suppression of pathogen-mediated interleukin-10 in THP-1 cells. FEMS Immunol Med Microbiol 49, 205-214.
191. Kim, H. J., Yang, J. S., Woo, S. S., et al. (2007b). Lipoteichoic acid and muramyl dipeptide synergistically induce maturation of human dendritic cells and concurrent expression of proinflammatory cytokines. J Leukoc Biol 81, 983-989.
192. Kim, H. G., Kim, N. R., Gim, M. G., et al. (2008). Lipoteichoic acid isolated from Lactobacillus plantarum inhibits lipopolysaccharide-induced TNF-Alpha production in THP-1 cells and endotoxin shock in mice. J Immunol 180, 2553-2561.
193. Kindinger, I., Daneshian, M., Baur, H., et al. (2005). A new method to measure air-borne pyrogens based on human whole blood cytokine response. J Immunol Methods 298, 143-153.
194. Kleszynski, R. R., Hoffman, D., Odeneal, A., et al. (1982). Apparent influence of adrenocorticotrophic hormone (ACTH) in the USP rabbit pyrogen test and evaluation of LALas an alternative procedure. Prog Clin Biol Res 93, 357-363.
195. Kluger, M. J. (1991). Fever: role of pyrogens and cryogens. Physiol Rev 71, 93-127.
196. Knapp, S., von Aulock, S., Leendertse, M., et al. (2008). Lipoteichoic acid-induced lung inflammation depends on TLR2 and the concerted action of TLR4 and the platelet-Activating factor receptor. J Immunol 180, 3478-3484.
197. Kobayashi, K., Inohara, N., Hernandez, L. D., et al. (2002). RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature 416, 194-199.
198. Kobayashi, K. S., Chamaillard, M., Ogura, Y., et al. (2005). Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 307, 731-734.
199. Kruger, T., Sigsgaard, T., and Bonefeld-Jorgensen, E. C. (2004). Ex vivo induction of cytokines by mould components in whole blood of atopic and non-Atopic volunteers. Cytokine 25, 73-84.
200. Kurokawa, M., Imakita, M., Kumeda, C. A., et al. (1996). Cascade of fever production in mice infected with influenza virus. J Med Virol 50, 152-158.
201. Lagrelius, M., Jones, P., Franck, K., et al. (2006). Cytokine detection by multiplex technology useful for assessing antigen specific cytokine profiles and kinetics in whole blood cultured up to seven days. Cytokine 33, 156-165.
202. Langer, M., Malykhin, A., Maeda, K., et al. (2008). Bacillus anthracis peptidoglycan stimulates an inflammatory response in monocytes through the p38 mitogen-Activated protein kinase pathway. PLoS One 3, e3706.
203. Langezaal, I., Hoffmann, S., Hartung, T., et al. (2002). Evaluation and prevalidation of an immunotoxicity test based on human whole-blood cytokine release. Altern Lab Anim 30, 581-595.
204. Lear, G. And Lewis, G. D. (2012). Microbial Biofilms: Current Research and Applications. Vol. Caister Academic Press. http://books.google.de/books? isbn=1904455964
205. Lehner, M. D., Morath, S., Michelsen, K. S., et al. (2001). Induction of cross-tolerance by lipopolysaccharide and highly purified lipoteichoic acid via different Toll-like receptors independent of paracrine mediators. J Immunol 166, 5161-5167.
206. Levels, J. H., Abraham, P. R., van Barreveld, E. P., et al. (2003). Distribution and kinetics of lipoprotein-bound lipoteichoic acid. Infect Immun 71, 3280-3284.
207. Levin, J. And Bang, F. B. (1964). The Role of Endotoxin in the Extracellular Coagulation of Limulus Blood. Bull Johns Hopkins Hosp 115, 265-274.
208. Liebers, V., Stubel, H., Duser, M., et al. (2009). Standardization of whole blood assay for determination of pyrogenic activity in organic dust samples. Int J Hyg Environ Health 212, 547-556.
209. Lien, E., Sellati, T. J., Yoshimura, A., et al. (1999). Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J Biol Chem 274, 33419-33425.
210. Lien, E. And Ingalls, R. R. (2002). Toll-like receptors. Crit Care Med 30, S1-S11.
211. Liljeroos, M., Vuolteenaho, R., Morath, S., et al. (2007). Bruton's tyrosine kinase together with PI 3-kinase are part of Toll-like receptor 2 multiprotein complex and mediate LTA induced Toll-like receptor 2 responses in macrophages. Cell Signal 19, 625-633.
212. Loeb, L. (1903). The Influence of certain Bacteria on the Coagulation of the Blood. J Med Res 10, 407-419.
213. Lotz, S., Aga, E., Wilde, I., et al. (2004). Highly purified lipoteichoic acid activates neutrophil granulocytes and delays their spontaneous apoptosis via CD14 and TLR2. J Leukoc Biol 75, 467-477.
214. Loverock, B., Simon, B., Burgenson, B., et al. (2010). A Recombinant Factor C Procedure for the Detection of Gram-negative Bacterial Endotoxin. Pharmacopeial Forum 36, 321-329.
215. Lynch, N. J., Roscher, S., Hartung, T., et al. (2004). L-ficolin specifically binds to lipoteichoic acid, a cell wall constituent of Gram-positive bacteria, and activates the lectin pathway of complement. J Immunol 172, 1198-1202.
216. Lyratzopoulos, G., Ellis, M., Nerringer, R., et al. (2002). Invasive infection due to penicillium species other than P. marneffei. J Infect 45, 184-195.
217. Mangram, A. J., Archibald, L. K., Hupert, M., et al. (1998). Outbreak of sterile peritonitis among continuous cycling peritoneal dialysis patients. Kidney Int 54, 1367-1371.
218. Marion-Ferey, K., Leid, J. G., Bouvier, G., et al. (2005). Endotoxin level measurement in hemodialysis biofilm using "the whole blood assay". Artif Organs 29, 475-481.
219. Martis, L., Patel, M., Giertych, J., et al. (2005). Aseptic peritonitis due to peptidoglycan contamination of pharmacopoeia standard dialysis solution. Lancet 365, 588-594.
220. Mathiak, G., Kabir, K., Grass, G., et al. (2003). Lipopolysaccharides from different bacterial sources elicit disparate cytokine responses in whole blood assays. Int J Mol Med 11, 41-44.
221. Mayilyan, K. R., Krarup, A., Soghoyan, A. F., et al. (2007). MBL and L-ficolin components of the complement activation lectin pathway in schizophrenia. Mol Immunol 44, 3940.
222. Mazzotti, F., Beuttler, J., Zeller, R., et al. (2007). In vitro pyrogen test - A new test method for solid medical devices. J Biomed Mater Res A 80, 276-282.
223. McCurdy, J. D., Olynych, T. J., Maher, L. H., et al. (2003). Cutting edge: distinct Toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells. J Immunol 170, 1625-1629.
224. Medzhitov, R., Preston-Hurlburt, P., and Janeway, C. A., Jr. (1997). A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388, 394-397.
225. Mereghetti, L., Sitkiewicz, I., Green, N. M., et al. (2009). Identification of an unusual pattern of global gene expression in group B Streptococcus grown in human blood. PLoS One 4, e7145.
226. Meron-Sudai, S., Matityahou, A., Keisari, Y., et al. (2008). Lipoteichoic acid synergizes with glycosphingolipids to potently stimulate secretion of interleukin-6 from human blood cells. Clin Vaccine Immunol 15, 1309-1315.
227. Michelsen, K. S., Aicher, A., Mohaupt, M., et al. (2001). The role of toll-like receptors (TLRs) in bacteria-induced maturation of murine dendritic cells (DCS). Peptidoglycan and lipoteichoic acid are inducers of DC maturation and require TLR2. J Biol Chem 276, 25680-25686.
228. Miller, K. M. And Anderson, J. M. (1988). Human monocyte/macrophage activation and interleukin 1 generation by biomedical polymers. J Biomed Mater Res 22, 713-731.
229. Mirelman, D., Shaw, D. R., and Park, J. T. (1971). Nature and origins of phosphorus compounds in isolated cell walls of Staphylococcus aureus. J Bacteriol 107, 239-244.
230. Miyake, K. (2003). Innate recognition of lipopolysaccharide by CD14 and toll-like receptor 4-MD-2: unique roles for MD-2. Int Immunopharmacol 3, 119-128.
231. Moesby, L., Hansen, E. W., and Christensen, J. D. (1997). Pyrogen testing of lipid-based TPN using Mono Mac 6 monocyte cell line and DELFIA. J Clin Pharm Ther 22, 327-333.
232. Moesby, L., Jensen, S., Hansen, E. W., et al. (1999). A comparative study of Mono Mac 6 cells, isolated mononuclear cells and Limulus amoebocyte lysate assay in pyrogen testing. Int J Pharm 191, 141-149.
233. Moltz, H. (1993). Fever: causes and consequences. Neurosci Biobehav Rev 17, 237-269.
234. Montag, T., Spreitzer, I., Loschner, B., et al. (2007). Safety testing of cell-based medicinal products: opportunities for the monocyte activation test for pyrogens. ALTEX 24, 81-89.
235. Montag-Lessing, T., Störmer, M., Schurig, U., et al. (2010). Probleme der mikrobiellen Sicherheit bei neuartigen Therapien. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 53, 45-51.
236. Morath, S., Geyer, A., and Hartung, T. (2001). Structure-function relationship of cytokine induction by lipoteichoic acid from Staphylococcus aureus. J Exp Med 193, 393-397.
237. Morath, S., Geyer, A., Spreitzer, I., et al. (2002a). Structural decomposition and heterogeneity of commercial lipoteichoic Acid preparations. Infect Immun 70, 938-944.
238. Morath, S., Stadelmaier, A., Geyer, A., et al. (2002b). Synthetic lipoteichoic acid from Staphylococcus aureus is a potent stimulus of cytokine release. J Exp Med 195, 1635-1640.
239. Morath, S., von Aulock, S., and Hartung, T. (2005). Structure/function relationships of lipoteichoic acids. J Endotoxin Res 11, 348-356.
240. Mueller, M., Stamme, C., Draing, C., et al. (2006). Cell activation of human macrophages by lipoteichoic acid is strongly attenuated by lipopolysaccharide-binding protein. J Biol Chem 281, 31448-31456.
241. Muhlradt, P. F., Kiess, M., Meyer, H., et al. (1997). Isolation, structure elucidation, and synthesis of a macrophage stimulatory lipopeptide from Mycoplasma fermentans acting at picomolar concentration. J Exp Med 185, 1951-1958.
242. Murai, T., Nakagawa, Y., and Ogawa, Y. (1996). Potentiation of lethal endotoxin shock by streptococcal pyrogenic exotoxin in rabbits: possible relevance of hyperreactivity of macrophages to endotoxin. FEMS Immunol Med Microbiol 13, 269-272.
243. Murciano, C., Villamon, E., Yanez, A., et al. (2007). In vitro response to Candida albicans in cultures of whole human blood from young and aged donors. FEMS Immunol Med Microbiol 51, 327-335.
244. Murphy, P. A. (1991). Exogenous pyrogens. In P. Mackowiak (eds.), Fever: Basic Mechanism and Management. New York, USA: Raven Press.
245. Nakagawa, Y., Maeda, H., and Murai, T. (2002). Evaluation of the in vitro pyrogen test system based on proinflammatory cytokine release from human monocytes: comparison with a human whole blood culture test system and with the rabbit pyrogen test. Clin Diagn Lab Immunol 9, 588-597.
246. Nakamura, T., Nitta, H., and Ishikawa, I. (2004). Effect of low dose Actinobacillus actinomycetemcomitans lipopolysaccharide pretreatment on cytokine production by human whole blood. J Periodontal Res 39, 129-135.
247. Nakata, T., Yasuda, M., Fujita, M., et al. (2006). CD14 directly binds to triacylated lipopeptides and facilitates recognition of the lipopeptides by the receptor complex of Toll-like receptors 2 and 1 without binding to the complex. Cell Microbiol 8, 1899-1909.
248. Natsuka, M., Uehara, A., Yang, S., et al. (2008). A polymer-type water-soluble peptidoglycan exhibited both Toll-like receptor 2- and NOD2-Agonistic activities, resulting in synergistic activation of human monocytic cells. Innate Immun 14, 298-308.
249. Nilsen, N. J., Deininger, S., Nonstad, U., et al. (2008). Cellular trafficking of lipoteichoic acid and Toll-like receptor 2 in relation to signaling: role of CD14 and CD36. J Leukoc Biol 84, 280-291.
250. Obayashi, T., Yoshida, M., Mori, T., et al. (1995). Plasma (1-3)-beta-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet 345, 17-20.
251. Opitz, B., Schroder, N. W., Spreitzer, I., et al. (2001). Toll-like receptor-2 mediates Treponema glycolipid and lipoteichoic acid-induced NF-kappaB translocation. J Biol Chem 276, 22041-22047.
252. Oscarsson, J., Karched, M., Thay, B., et al. (2008). Proinflammatory effect in whole blood by free soluble bacterial components released from planktonic and biofilm cells. BMC Microbiol 8, 206.
253. Ozinsky, A., Underhill, D. M., Fontenot, J. D., et al. (2000). The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc Natl Acad Sci U S A 97, 13766-13771.
254. Patterson, T. F. (2005). Advances and challenges in management of invasive mycoses. Lancet 366, 1013-1025.
255. Pearson, F. C., Weary, M., and Jorgensen, J. H. (1985). Pyrogens: Endotoxins, LAL testing, and depyrogenation. Vol. New York: Dekker.
256. Perdomo-Morales, R., Pardo-Ruiz, Z., Spreitzer, I., et al. (2011). Monocyte activation test (MAT) reliably detects pyrogens in parenteral formulations of human serum albumin. ALTEX 28, 227-235.
257. Petri, E. And Fennrich, S. (2000). Improved detection of pyrogenic substances with an ex vivo human whole-blood assay in comparison to the Limulus amoebocyte lysate test. In Balls, M., Van Zeller, A.-M., and Halder, M.E., (eds.), Progress in the reduction, refinement and replacement of animal experimentation. Elsevier.
258. Pfeiffer, A., Bottcher, A., Orso, E., et al. (2001). Lipopolysaccharide and ceramide docking to CD14 provokes ligand-specific receptor clustering in rafts. Eur J Immunol 31, 3153-3164.
259. Plitnick, L. M., Jordan, R. A., Banas, J. A., et al. (2001). Lipoteichoic acid inhibits interleukin-2 (IL-2) function by direct binding to IL-2. Clin Diagn Lab Immunol 8, 972-979.
260. Pool, E. J., Johaar, G., James, S., et al. (1998). The detection of pyrogens in blood products using an ex vivo whole blood culture assay. J Immunoassay 19, 95-111.
261. Pool, E. J., Johaar, G., James, S., et al. (1999). Differentiation between endotoxin and non-endotoxin pyrogens in human albumin solutions using an ex vivo whole blood culture assay. J Immunoassay 20, 79-89.
262. Pool, M. And McLeod, B. C. (1995). Pyrogen reactions to human serum albumin during plasma exchange. J Clin Apher 10, 81-84.
263. Poole, S., Thorpe, R., Meager, A., et al. (1988a). Assay of pyrogenic contamination in pharmaceuticals by cytokine release from monocytes. Dev Biol Stand 69, 121-123.
264. Poole, S., Thorpe, R., Meager, A., et al. (1988b). Detection of pyrogen by cytokine release. Lancet 1, 130.
265. Poole, S., Dawson, P., and Gaines Das, R. E. (1997). Second international standard for endotoxin: calibration in an international collaborative study. J Endotoxin Res 4, 221-231.
266. Popa, C., Netea, M. G., Barrera, P., et al. (2005). Cytokine production of stimulated whole blood cultures in rheumatoid arthritis patients receiving short-term infliximab therapy. Cytokine 30, 72-77.
267. Popa, C., Barrera, P., Joosten, L. A., et al. (2009). Cytokine production from stimulated whole blood cultures in rheumatoid arthritis patients treated with various TNF blocking agents. Eur Cytokine Netw 20, 88-93.
268. Price, G. E., Fenton, R. J., Smith, H., et al. (1997). Are known pyrogenic cytokines responsible for fever in influenza? J Med Virol 52, 336-340.
269. Probey, T. F. And Pittman, M. (1945). The pyrogenicity of bacterial contaminants found in biologic products. J Bacteriol 50, 397-411.
270. Rarick, M., McPheeters, C., Bright, S., et al. (2006). Evidence for cross-regulated cytokine response in human peripheral blood mononuclear cells exposed to whole gonococcal bacteria in vitro. Microb Pathog 40, 261-270.
271. Rawadi, G. And Roman-Roman, S. (1996). Mycoplasma membrane lipoproteins induced proinflammatory cytokines by a mechanism distinct from that of lipopolysaccharide. Infect Immun 64, 637-643.
272. Rivera-Mariani, F., Vysyaraju, K., Levetin, E., et al. (2012). Determination of the proinflammatory potential of spores from different basidiomycetes species with a human whole blood assay. J Immunol 188 (Meeting Abstract Supplement), 55.13.
273. Rockel, C., Hartung, T., and Hermann, C. (2011). Different Staphylococcus aureus whole bacteria mutated in putative pro-inflammatory membrane components have similar cytokine inducing activity. Immunobiology 216, 316-321.
274. Rockel, C. And Hartung, T. (2012). Systematic review of membrane components of gram-positive bacteria responsible as pyrogens for inducing human monocyte/macrophage cytokine release. Front Pharmacol 3, 56.
275. Roggiani, M., Stoehr, J. A., Leonard, B. A., et al. (1997). Analysis of toxicity of streptococcal pyrogenic exotoxin A mutants. Infect Immun 65, 2868-2875.
276. Roslansky, P. F., Dawson, M. E., and Novitsky, T. J. (1991). Plastics, endotoxins, and the Limulus amebocyte lysate test. J Parenter Sci Technol 45, 83-87.
277. Roslansky, P. F. And Novitsky, T. J. (1991). Sensitivity of Limulus amebocyte lysate (LAL) to LAL-reactive glucans. J Clin Microbiol 29, 2477-2483.
278. Ross, V. C. And Bruch, C. W. (1982). Endotoxin testing of medical devices with LAL: FDA requirements. Prog Clin Biol Res 93, 39-48.
279. Sancho, D. And Reis e Sousa, C. (2012). Signaling by myeloid C-type lectin receptors in immunity and homeostasis. Annu Rev Immunol 30, 491-529.
280. Schindler, R., Eichert, F., Lepenies, J., et al. (2001). Blood components influence cytokine induction by bacterial substances. Blood Purif 19, 380-387.
281. Schindler, S., Bristow, A., Cartmell, T., et al. (2003). Comparison of the reactivity of human and rabbit blood towards pyrogenic stimuli. ALTEX 20, 59-63.
282. Schindler, S., Asmus, S., von Aulock, S., et al. (2004). Cryopreservation of human whole blood for pyrogenicity testing. J Immunol Methods 294, 89-100.
283. Schindler, S. (2006). Optimization and novel applications of the in vitro pyrogen test (IPT) using human whole blood. PhD, University of Konstanz, Konstanz, Germany. http://d-nb.info/980889332/34
284. Schindler, S., Rosenberg, U., Schlote, D., et al. (2006a). Pyrogen testing of lipidic parenterals with a novel in vitro test - application of the IPTbased on cryopreserved human whole blood. Pharmeur Sci Notes 2006, 1-7.
285. Schindler, S., Spreitzer, I., Loschner, B., et al. (2006b). International validation of pyrogen tests based on cryopreserved human primary blood cells. J Immunol Methods 316, 42-51.
286. Schindler, S., von Aulock, S., Daneshian, M., et al. (2009). Development, validation and applications of the monocyte activation test for pyrogens based on human whole blood. ALTEX 26, 265-277.
287. Schmidtgen, M. And Brandl, M. (1995). Detection of lipopolysaccharides in phospholipids and liposomes using the limulus test. Journal of Liposome Research 5, 109-116.
288. Schrijver, I. A., Melief, M. J., Eulderink, F., et al. (1999). Bacterial peptidoglycan polysaccharides in sterile human spleen induce proinflammatory cytokine production by human blood cells. J Infect Dis 179, 1459-1468.
289. Schroder, N. W., Morath, S., Alexander, C., et al. (2003). Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved. J Biol Chem 278, 15587-15594.
290. Schroder, N. W., Heine, H., Alexander, C., et al. (2004). Lipopolysaccharide binding protein binds to triacylated and diacylated lipopeptides and mediates innate immune responses. J Immunol 173, 2683-2691.
291. Schroder, N. W., Diterich, I., Zinke, A., et al. (2005). Heterozygous Arg753Gln polymorphism of human TLR-2 impairs immune activation by Borrelia burgdorferi and protects from late stage Lyme disease. J Immunol 175, 2534-2540.
292. Schromm, A. B., Howe, J., Ulmer, A. J., et al. (2007). Physicochemical and biological analysis of synthetic bacterial lipopeptides: validity of the concept of endotoxic conformation. J Biol Chem 282, 11030-11037.
293. Schwandner, R., Dziarski, R., Wesche, H., et al. (1999). Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J Biol Chem 274, 17406-17409.
294. Segura, M., Vanier, G., Al-Numani, D., et al. (2006). Proinflammatory cytokine and chemokine modulation by Streptococcus suis in a whole-blood culture system. FEMS Immunol Med Microbiol 47, 92-106.
295. Seo, H. S., Michalek, S. M., and Nahm, M. H. (2008). Lipoteichoic acid is important in innate immune responses to gram-positive bacteria. Infect Immun 76, 206-213.
296. Shirodkar, M. V., Warwick, A., and Bang, F. B. (1960). The in vitro reaction of limulus amebocytes to bacteria. Biol Bull 118, 324-337.
297. Sieling, P. A., Chung, W., Duong, B. T., et al. (2003). Toll-like receptor 2 ligands as adjuvants for human Th1 responses. J Immunol 170, 194-200.
298. Sigsgaard, T., Bonefeld-Jorgensen, E. C., Kjaergaard, S. K., et al. (2000). Cytokine release from the nasal mucosa and whole blood after experimental exposures to organic dusts. Eur Respir J 16, 140-145.
299. Smulders, S., Kaiser, J. P., Zuin, S., et al. (2012). Contamination of nanoparticles by endotoxin: evaluation of different test methods. Part Fibre Toxicol 9, 41.
300. Soprana, E., Vigo, E., Verani, A., et al. (1994). Antiidiotypic antibodies mimic molecular and functional properties of human IL-1 beta in vitro and in vivo. Lymphokine Cytokine Res 13, 325-330.
301. Sparwasser, T., Miethke, T., Lipford, G., et al. (1997). Bacterial DNA causes septic shock. Nature 386, 336-337.
302. Spreitzer, I., Fischer, M., Hartzsch, K., et al. (2002). Comparative study of rabbit pyrogen test and human whole blood assay on human serum albumin. ALTEX 19, Suppl 1, 73-75.
303. Spreitzer, I., Löschner, B., Schneider, C. K., et al. (2008). 10 years of experience with alternative pyrogen tests (monocyte activation tests). AATEX 14, 587-589.
304. Sriskandan, S. And Cohen, J. (1999). Gram-positive sepsis. Mechanisms and differences from gram-negative sepsis. Infect Dis Clin North Am 13, 397-412.
305. Stadelmaier, A., Morath, S., Hartung, T., et al. (2003). Synthesis of the first fully active lipoteichoic acid. Angew Chem Int Ed Engl 42, 916-920.
306. Stadelmaier, A., Figueroa-Perez, I., Deininger, S., et al. (2006). A Staphylococcus aureus lipoteichoic acid (LTA) derived structural variant with two diacylglycerol residues. Bioorg Med Chem 14, 6239-6254.
307. Stark, P. C., Burge, H. A., Ryan, L. M., et al. (2003). Fungal levels in the home and lower respiratory tract illnesses in the first year of life. Am J Respir Crit Care Med 168, 232-237.
308. Steere, A. C., Rifaat, M. K., Seligmann, E. B., Jr., et al. (1978). Pyrogen reactions associated with the infusion of normal serum albumin (human). Transfusion 18, 102-107.
309. Stoddard, M. B., Pinto, V., Keiser, P. B., et al. (2010). Evaluation of a whole-blood cytokine release assay for use in measuring endotoxin activity of group B Neisseria meningitidis vaccines made from lipid A acylation mutants. Clin Vaccine Immunol 17, 98-107.
310. Strunk, T., Power Coombs, M. R., Currie, A. J., et al. (2010). TLR2 mediates recognition of live Staphylococcus epidermidis and clearance of bacteremia. PLoS One 5, e10111.
311. Szreder, Z. (1997). Do cardiovascular mechanisms participate in thermoregulatory activity of alpha 2-Adrenoceptor agonists and antagonists in rabbits? Ann N Y Acad Sci 813, 512-525.
312. Takeuchi, O., Hoshino, K., Kawai, T., et al. (1999). Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 11, 443-451.
313. Takeuchi, O., Kaufmann, A., Grote, K., et al. (2000). Cutting edge: preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-Activating lipopeptide-2 activates immune cells through a toll-like receptor 2- and MyD88-dependent signaling pathway. J Immunol 164, 554-557.
314. Taktak, Y. S., Selkirk, S., Bristow, A. F., et al. (1991). Assay of pyrogens by interleukin-6 release from monocytic cell lines. J Pharm Pharmacol 43, 578-582.
315. Tallant, T., Deb, A., Kar, N., et al. (2004). Flagellin acting via TLR5 is the major activator of key signaling pathways leading to NF-kappa B and proinflammatory gene program activation in intestinal epithelial cells. BMC Microbiol 4, 33.
316. Tanowitz, H. B. And Chan, J. (2000). Gram-positive sepsis. Crit Care Med 28, 3081-3082.
317. Thomsen, A. And Loppnow, H. (1995). Cytokine production by mononuclear cells following stimulation with a peptide-containing, endotoxin-free Escherichia coli extract. Arzneimittelforschung 45, 657-661.
318. Tietze, K., Dalpke, A., Morath, S., et al. (2006). Differences in innate immune responses upon stimulation with gram-positive and gram-negative bacteria. J Periodontal Res 41, 447-454.
319. Toien, O. And Mercer, J. B. (1996). Thermosensitivity is reduced during fever induced by Staphylococcus aureus cells walls in rabbits. Pflugers Arch 432, 66-74.
320. Traub, S., Kubasch, N., Morath, S., et al. (2004). Structural requirements of synthetic muropeptides to synergize with lipopolysaccharide in cytokine induction. J Biol Chem 279, 8694-8700.
321. Traub, S., von Aulock, S., Hartung, T., et al. (2006). MDP and other muropeptides - direct and synergistic effects on the immune system. J Endotoxin Res 12, 69-85.
322. Travassos, L. H., Girardin, S. E., Philpott, D. J., et al. (2004). Toll-like receptor 2-dependent bacterial sensing does not occur via peptidoglycan recognition. EMBO Rep 5, 1000-1006.
323. Triantafilou, M., Manukyan, M., Mackie, A., et al. (2004a). Lipoteichoic acid and toll-like receptor 2 internalization and targeting to the Golgi are lipid raft-dependent. J Biol Chem 279, 40882-40889.
324. Triantafilou, M., Morath, S., Mackie, A., et al. (2004b). Lateral diffusion of Toll-like receptors reveals that they are transiently confined within lipid rafts on the plasma membrane. J Cell Sci 117, 4007-4014.
325. Triantafilou, M., Gamper, F. G., Haston, R. M., et al. (2006). Membrane sorting of toll-like receptor (TLR)-2/6 and TLR2/1 heterodimers at the cell surface determines heterotypic associations with CD36 and intracellular targeting. J Biol Chem 281, 31002-31011.
326. Tsuji, K., Steindler, K. A., and Harrison, S. J. (1980). Limulus amoebocyte lysate assay for detection and quantitation of endotoxin in a small-volume parenteral product. Appl Environ Microbiol 40, 533-538.
327. Tui, F. W. And Schrift, M. H. (1942). A tentative test for pyrogen in infusion fluids. Exp Biol Med 49, 320-323.
328. Tuncer, M., Sarikaya, M., Sezer, T., et al. (2000). Chemical peritonitis associated with high dialysate acetaldehyde concentrations. Nephrol Dial Transplant 15, 2037-2040.
329. Uehara, A., Sugawara, S., and Takada, H. (2002). Priming of human oral epithelial cells by interferon-gamma to secrete cytokines in response to lipopolysaccharides, lipoteichoic acids and peptidoglycans. J Med Microbiol 51, 626-634.
330. Uehara, A., Yang, S., Fujimoto, Y., et al. (2005). Muramyldipeptide and diaminopimelic acid-containing desmuramylpeptides in combination with chemically synthesized Toll-like receptor agonists synergistically induced production of interleukin-8 in a NOD2- and NOD1-dependent manner, respectively, in human monocytic cells in culture. Cell Microbiol 7, 53-61.
331. Uehara, A., Fujimoto, Y., Kawasaki, A., et al. (2006). Meso-diaminopimelic acid and meso-lanthionine, amino acids specific to bacterial peptidoglycans, activate human epithelial cells through NOD1. J Immunol 177, 1796-1804.
332. Underhill, D. M. And Ozinsky, A. (2002). Toll-like receptors: key mediators of microbe detection. Curr Opin Immunol 14, 103-110.
333. Vallejo, J. G., Baker, C. J., and Edwards, M. S. (1996). Roles of the bacterial cell wall and capsule in induction of tumor necrosis factor alpha by type III group B streptococci. Infect Immun 64, 5042-5046.
334. van Dijck, P. And van de Voorde, H. (1977). Factors affecting pyrogen testing in rabbits. Dev Biol Stand 34, 57-63.
335. van Miert, A. S. And van Duin, C. T. (1978). Further studies on the antipyretic action of polymyxin B in pyrogen-induced fever. Arzneimittelforschung 28, 2246-2251.
336. Van Wauwe, J., Aerts, F., Walter, H., et al. (1995). Cytokine production by phytohemagglutinin-stimulated human blood cells: effects of corticosteroids, Tcell immunosuppressants and phosphodiesterase IV inhibitors. Inflamm Res 44, 400-405.
337. Vassallo, R. And Limper, A. H. (1999). Fungal beta-glucan can yield false-positive results with the limulus amebocyte lysate endotoxin assay. Chest 116, 583-584.
338. von Aulock, S., Morath, S., Hareng, L., et al. (2003). Lipoteichoic acid from Staphylococcus aureus is a potent stimulus for neutrophil recruitment. Immunobiology 208, 413-422.
339. von Aulock, S., Schroder, N. W., Traub, S., et al. (2004). Heterozygous toll-like receptor 2 polymorphism does not affect lipoteichoic acid-induced chemokine and inflammatory responses. Infect Immun 72, 1828-1831.
340. von Aulock, S., Hartung, T., and Hermann, C. (2007). Comment on "Not lipoteichoic acid but lipoproteins appear to be the dominant immunobiologically active compounds in Staphylococcus aureus". J Immunol 178, 2610; author reply 2610-2611.
341. Voropaev, A. V., Shurygina, I. A., Klimov, V. T., et al. (2002). [Impact of Yersinia pseudotuberculosis on the in vitro production of cytokines by whole blood cells of donors]. Zh Mikrobiol Epidemiol Immunobiol 48-51.
342. Wang, J. E., Jorgensen, P. F., Almlof, M., et al. (2000). Peptidoglycan and lipoteichoic acid from Staphylococcus aureus induce tumor necrosis factor alpha, interleukin 6 (IL-6), and IL-10 production in both Tcells and monocytes in a human whole blood model. Infect Immun 68, 3965-3970.
343. Wang, J. H., Doyle, M., Manning, B. J., et al. (2002). Induction of bacterial lipoprotein tolerance is associated with suppression of toll-like receptor 2 expression. J Biol Chem 277, 36068-36075.
344. Weary, M., Pearson, F. C., 3rd, Bohon, J., et al. (1982). The activity of various endotoxins in the USP rabbit test and in three different LALtests. Prog Clin Biol Res 93, 365-379.
345. Weary, M. E. And Wallin, R. F. (1973). The rabbit pyrogen test. Lab Anim Sci 23, 677-681.
346. Weary, M. E., Donohue, G., Pearson, F. C., et al. (1980). Relative potencies of four reference endotoxin standards as measured by the Limulus amoebocyte lysate and USP rabbit pyrogen tests. Appl Environ Microbiol 40, 1148-1151.
347. Werner-Felmayer, G., Baier-Bitterlich, G., Fuchs, D., et al. (1995). Detection of bacterial pyrogens on the basis of their effects on gamma interferon-mediated formation of neopterin or nitrite in cultured monocyte cell lines. Clin Diagn Lab Immunol 2, 307-313.
348. Wexler, H. And Oppenheim, J. D. (1979). Isolation, characterization, and biological properties of an endotoxin-like material from the gram-positive organism Listeria monocytogenes. Infect Immun 23, 845-857.
349. Williams, D. L., Sherwood, E. R., Browder, I. W., et al. (1988). Pre-clinical safety evaluation of soluble glucan. Int J Immunopharmacol 10, 405-414.
350. Williams, K. L. (2001). Nonendotoxin Microbial pyrogens: Lesser Endotoxins, Superantigens and Adventitious Agents. In J. Swarbrick (ed.), Endotoxins: Pyrogens, LAL Testing and Depyrogenation. New York, Basel: Marcel Dekker, Inc.
351. Wolfert, M. A., Murray, T. F., Boons, G. J., et al. (2002). The origin of the synergistic effect of muramyl dipeptide with endotoxin and peptidoglycan. J Biol Chem 277, 39179-39186.
352. Won, S. J. And Lin, M. T. (1993). Endogenous pyrogen formation by human blood monocytes stimulated by polyriboinosinic acid:polyribocytidylic acid. Experientia 49, 157-159.
353. Wouters, I. M., Douwes, J., Thorne, P. S., et al. (2002). Inter- and intraindividual variation of endotoxin- and beta(1-3)-glucan-induced cytokine responses in a whole blood assay. Toxicol Ind Health 18, 15-27.
354. Wu, Y., Qiu, H., Zeng, Y., et al. (2008). Mycoplasma genitalium lipoproteins induce human monocytic cell expression of proinflammatory cytokines and apoptosis by activating nuclear factor kappaB. Mediators Inflamm 2008, 195427.
355. Yoneyama, M. And Fujita, T. (2007). Function of RIG-I-like receptors in antiviral innate immunity. J Biol Chem 282, 15315-15318.
356. Yum, S., Woo, S., Kagami, Y., et al. (2010). Changes in gene expression profile of medaka with acute toxicity of Arochlor 1260, a polychlorinated biphenyl mixture. Comp Biochem Physiol C Toxicol Pharmacol 151, 51-56.
357. Zucker, B. A., Scharf, P., and Kersten, C. (2006). Determination of the inflammatory potential of bioaerosols from a duck-fattening unit by using a limulus amebocyte lysate assay and human whole blood cytokine response. J Vet Med B Infect Dis Vet Public Health 53, 176-180.